On December 23, Eastern Time, Moderna options saw a total of 122203 contracts traded, with calls accounting for 59% and puts making up 40%.
Moderna has 1074467 contracts outstanding, with calls accounting for 56% and puts making up 43%.
The top volume gainer was the 33 dollars Call option expiring on December 26, 2025, with 8439 contracts traded.
On the news front, Based on recent key news:

1. Dec 24, Moderna's stock dropped 5.8% due to profit-taking after a four-day win streak, trading at $32.89. Year-to-date, shares are down 20%. Source: 

2. Dec 24, Moderna's mRESVIA faces challenges in the competitive RSV vaccine market, impacting its financial outlook. Analysts maintain a 'Sell' rating. Source: 

3. Dec 22, Moderna's experimental bird flu shot in Phase 3 trials, with speculation of a potential buyout. Source: Biotech sector faces competitive pressures.
Please note: The chart below does not include options expiring within five days.
<img src="https://assets.lbctrl.com/h5hub/optrank/images/2025-12-24/ST_US_MRNA_en.png" alt="image" original-src="https://assets.lbctrl.com/h5hub/optrank/images/2025-12-24/ST_US_MRNA_en.png"/>

MRNA

On December 23, Eastern Time, Moderna options saw a total of 122203 contracts traded, with calls accounting for 59% and puts making up 40%.

Trending | MRNA Plummets 7% on Tuesday, Some Put options Soar 4300%